FIELD: pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to omeprazole pellet, process for its preparation, oral solid composition, use of pellet and method for treating and/or preventing gastrointestinal disorder. Pellet according to the claimed invention comprises a core of inert bead coated with a layer of omeprazole, hydroxypropylmethylcellulose, disodium phosphate dihydrate and talc, Intermediate layer and layer of enteric coating. Pellet of omeprazole is characterized by, that the mass fraction of the enteric coating is from 20 % w/w up to 40 % w/w in relation to the total mass, pellets and inert beads have a diameter from 0.7 mm to 0.9 mm.
EFFECT: implementation of the invention will allow to obtain a dosage form of omeprazole with improved stability.
15 cl, 10 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL COMPOSITION CONTAINING ACID-NONSTABLE OMEPRAZOLE AND METHOD OF ITS PREPARING | 1996 |
|
RU2161481C2 |
COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT | 2004 |
|
RU2372893C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
ENTERIC COATED PELLETS, METHOD FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM | 2021 |
|
RU2821366C1 |
PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
PHARMACEUTICAL COMPOSITION WITH ENTEROSOLUBLE COATING, METHOD OF ITS PREPARING, METHOD OF TREATMENT OF PATIENTS | 1994 |
|
RU2138254C1 |
THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT | 2006 |
|
RU2442574C2 |
MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF GASTRIC AND DUODENUM ULCER IN FORM OF SOLID GELATIN CAPSULES, WHICH CONTAINS RABEPRAZOLE OR ITS DERIVATIVES, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2414889C2 |
Authors
Dates
2018-03-15—Published
2012-10-31—Filed